| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 赵海春 | 国金证券 | 医药生物 | 234.75% | -11.98% | 5.27% | -25.00% | 1 | -61.07% | 2015-12-31 |
| 2 | 刘浩 | 华创证券 | 医药生物 | 111.35% | 93.17% | 44.89% | 29.41% | 2 | -47.33% | 2025-08-25 |
| 3 | 刘浩 | 华创证券 | 医药生物 | 107.72% | 84.24% | 22.23% | 29.41% | 3 | -47.33% | 2025-09-03 |
| 4 | 刘浩 | 华创证券 | 医药生物 | 106.45% | 76.49% | 26.93% | 29.41% | 3 | -47.33% | 2025-09-01 |
| 5 | 刘浩 | 华创证券 | 医药生物 | 104.93% | 101.30% | 52.23% | 29.41% | 2 | -47.33% | 2025-08-19 |
| 6 | 刘浩 | 华创证券 | 医药生物 | 104.75% | 75.03% | 25.88% | 29.41% | 3 | -47.33% | 2025-09-02 |
| 7 | 刘浩 | 华创证券 | 医药生物 | 103.68% | 78.18% | 41.83% | 29.41% | 2 | -47.33% | 2025-08-26 |
| 8 | 刘浩 | 华创证券 | 医药生物 | 103.35% | 73.84% | 39.42% | 29.41% | 2 | -47.33% | 2025-08-28 |
| 9 | 刘浩 | 华创证券 | 医药生物 | 103.29% | 68.15% | 23.91% | 29.41% | 3 | -47.33% | 2025-09-05 |
| 10 | 刘浩 | 华创证券 | 医药生物 | 103.20% | 73.71% | 33.73% | 29.41% | 2 | -47.33% | 2025-08-29 |
| 11 | 刘浩 | 华创证券 | 医药生物 | 101.12% | 97.00% | 48.31% | 29.41% | 2 | -47.33% | 2025-08-18 |
| 12 | 刘浩 | 华创证券 | 医药生物 | 100.48% | 103.32% | 40.18% | 29.41% | 2 | -47.33% | 2025-08-05 |
| 13 | 刘浩 | 华创证券 | 医药生物 | 100.29% | 66.05% | 40.05% | 29.41% | 2 | -47.33% | 2025-08-04 |
| 14 | 刘浩 | 华创证券 | 医药生物 | 99.86% | 67.16% | 20.28% | 29.41% | 3 | -47.33% | 2025-09-04 |
| 15 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 99.77% | 76.41% | 17.14% | 9.68% | 9 | -27.10% | 2025-09-01 |
| 16 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 99.14% | 72.92% | 15.20% | 9.68% | 9 | -27.10% | 2025-09-03 |
| 17 | 刘浩 | 华创证券 | 医药生物 | 99.14% | 63.73% | 18.63% | 29.41% | 3 | -47.33% | 2025-09-08 |
| 18 | 刘浩 | 华创证券 | 医药生物 | 98.77% | 67.96% | 10.98% | 29.41% | 3 | -47.33% | 2025-09-12 |
| 19 | 刘浩 | 华创证券 | 医药生物 | 98.61% | 63.29% | 15.45% | 29.41% | 3 | -47.33% | 2025-09-09 |
| 20 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 98.44% | 64.78% | 14.87% | 9.68% | 9 | -27.10% | 2025-09-05 |